Develop and implement integrated communications activities in support of oncology in-line products and Phase 3 pipeline assets; heavy emphasis on data milestone communications (data releases, medical meeting communications) and regulatory milestones and approvals. Drive integrated editorial strategy to raise external awareness of late-stage oncology pipeline assets – through conducting meaningful, targeted communication outreach including social and digital channels that enhance the reputation of our Company. Include appropriate metrics and leverage with key audiences. Identify, develop and support unique storylines, media and thought-leadership opportunities to showcase our late-stage oncology pipeline assets that complement oncology narrative with key external stakeholders. Prepare and brief oncology leaders on message delivery, media engagement and external speaking opportunities. Develop and communicate strategies, programs and materials for use by our company’s regions and subsidiaries worldwide; help advise regions and subsidiaries for franchise and product communications issues. Serve as a liaison to third party groups (including advocacy organizations) and external experts (including researchers) and to trade and local news media. Manage high volume of materials (press releases, social media content, core response documents, etc.) through medical and legal review process, developing strong and collaborative relationships with review boards. Work directly with public relations agencies and help manage related budgets.